MediPharm Labs Corp. (OTCMKTS:MEDIF – Get Free Report) was the target of a large drop in short interest in August. As of August 31st, there was short interest totaling 997 shares, a drop of 94.3% from the August 15th total of 17,636 shares. Based on an average daily volume of 108,289 shares, the short-interest ratio is currently 0.0 days.
MediPharm Labs Price Performance
MEDIF stock traded down $0.00 on Friday, reaching $0.05. The company had a trading volume of 404 shares, compared to its average volume of 78,342. The company’s fifty day moving average is $0.05 and its 200 day moving average is $0.05. MediPharm Labs has a 1 year low of $0.04 and a 1 year high of $0.08.
MediPharm Labs Company Profile
MediPharm Labs Corporation is a Canada-based company focused on the extraction, formulation and manufacturing of pharmaceutical-grade cannabis products. Through proprietary processes and a GMP-compliant facility in Mississauga, Ontario, the company produces high-purity distillates, isolates and advanced formulations tailored to both medical and adult-use markets.
The company’s core offerings include THC and CBD distillates, crystalline isolates, softgel capsules, oral thin films and sterile injectable products.
Featured Stories
- Five stocks we like better than MediPharm Labs
- Oracle’s AI Spending Is Still Huge, But the Payoff Is Starting to Show in Earnings
- TSMC Revenue Jumps 53% in August, Signaling Strong AI Chip Demand
- This AI ETF Is Missing the Biggest AI Winners
- Could Snowflake’s Big Quarter Be a Sign of More to Come?
Receive News & Ratings for MediPharm Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MediPharm Labs and related companies with MarketBeat.com's FREE daily email newsletter.
